A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

Cited by (1,001)

Items 101–200 of 1,001

1. Update on recommendations for use of herpes zoster vaccine.
   Craig M. Hales, Rafael Harpaz, Ismael R. Ortega‐Sanchez, Stephanie R. Bialek · 2014 · PubMed Central
2. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
   Branca Isabel Pereira, Xiao‐Ning Xu, Arne N. Akbar · 2020 · Frontiers in Immunology
3. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10‐year survey of 48,388 herpes zoster cases in Miyazaki prefecture
   Nozomu Toyama, Kimiyasu Shiraki, and Members of the Society of the Miyazaki Prefecture Dermatologists · 2009 · Journal of Medical Virology
4. Herpes Zoster Eye Complications: Rates and Trends
   Barbara P. Yawn, Peter C. Wollan, Jennifer L. St. Sauver, Linda C. Butterfield · 2013 · Mayo Clinic Proceedings
5. Vaccines for preventing herpes zoster in older adults
   Anna MZ Gagliardi, Brenda NG Andriolo, Maria Regina Torloni, Bernardo GO Soares · 2016 · Cochrane Database of Systematic Reviews
6. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study
   Leonardo Emberti Gialloreti, Monica Merito, Patrizio Pezzotti, Luigi Naldi, Antonio Gatti, Maud Beillat, Laurence Serradell, Rafaelle di Marzo, Antonio Volpi · 2010 · BMC Infectious Diseases
7. Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
   James Benjamin Galloway, Louise Mercer, Alison Moseley, William Gregory Dixon, Andrew Ustianowski, MATTHEW HELBERT, Kath D. Watson, Mark Lunt, Kimme Leanne Hyrich, Deborah P. M. Symmons · 2012 · Annals of the Rheumatic Diseases
8. Varicella–Zoster Vaccine for the Prevention of Herpes Zoster
   David Winston Kimberlin, Richard J. Whitley · 2007 · New England Journal of Medicine
9. Blue Journal Conference. Aging and Susceptibility to Lung Disease
   Victor John Thannickal, Mahadev Murthy, William E. Balch, Navdeep S. Chandel, Silke Meiners, Oliver Eickelberg, Moisés Selman, Annie Pardo, Eric S. White, Bruce D. Levy et al. · 2015 · American Journal of Respiratory and Critical Care Medicine
10. Status of vaccine research and development of vaccines for herpes simplex virus
    Christine Johnston, Sami L. Gottlieb, Anna Wald · 2016 · Vaccine
11. The Impact of Acute Herpes Zoster Pain and Discomfort on Functional Status and Quality of Life in Older Adults
    Kenneth E. Schmader, Richard Sloane, Carl F. Pieper, PAUL M. COPLAN, Alexander A. Nikas, Patricia Saddier, Ivan S. F. Chan, Peter W. Choo, Myron J. Levin, Gary R. Johnson et al. · 2007 · Clinical Journal of Pain
12. Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice
    Didier Bouhassira, Olivier Chassany, Jacques Gaillat, Thomas Hanslik, Odile Launay, Claude Mann, Christian Rabaud, O. Rogeaux, Christophe Strady · 2011 · Pain
13. Vaccines for the elderly: current use and future challenges
    Birgit Weinberger · 2018 · Immunity & Ageing
14. Age-related changes in immunity: implications for vaccination in the elderly
    Rania D. Kovaiou, Dietmar Herndler‐Brandstetter, Beatrix Grubeck‐Loebenstein · 2007 · Expert Reviews in Molecular Medicine
15. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis
    Andrea C. Tricco, Wasifa Zarin, Roberta Cardoso, Areti Angeliki Veroniki, Paul A. Khan, Vera Nincic, Marco Ghassemi, Rachel Warren, Jane Pearson Sharpe, Andrea V. Page et al. · 2018 · BMJ
16. Understanding immunosenescence and its impact on vaccination of older adults
    Jessica C. Allen, Franklin R. Toapanta, Wilbur H. Chen, Sharon M. Tennant · 2020 · Vaccine
17. Safety and Immunogenicity of Varicella-Zoster Virus Vaccine in Pediatric Liver and Intestine Transplant Recipients
    Adriana Weinberg, Simon Peter Horslen, Stuart S. Kaufman, Renee D. Jesser, Anne DeVoll‐Zabrocki, Beverly Fleckten, S. Kochanowicz, K.R. Seipel, Myron J. Levin · 2006 · American Journal of Transplantation
18. Herpesvirus infections of the nervous system
    Donald H. Gilden, Ravi Mahalingam, Randall J. Cohrs, Kenneth L. Tyler · 2007 · Nature Clinical Practice Neurology
19. Infections in the Elderly Critically-Ill Patients
    Mert Eşme, Arzu Topeli̇, Burcu Balam Doğu, Murat Akova · 2019 · Frontiers in Medicine
20. Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
    Albert Jan van Hoek, N Gay, Alessia Melegaro, Wim Opstelten, W. John Edmunds · 2009 · Vaccine
21. Transcranial magnetic stimulation of the brain
    Max M. Klein, Roi Treister, Tommi Raij, Álvaro Pascual‐Leone, Lawrence Park, Turo J Nurmikko, Fred A. Lenz, Jean‐Pascal Lefaucheur, Magdalena Lang, Mark Hallett et al. · 2015 · Pain
22. Age-related decline in immunity: implications for vaccine responsiveness
    Rajesh Kumar, Edith A. Burns · 2008 · Expert Review of Vaccines
23. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
    Rondaan, Christien, Furer, Victoria, Heijstek, Marloes W, Agmon-Levin, Nancy, Bijl, Marc, Breedveld, Ferdinand C, D’Amelio, Raffaele, Dougados, Maxime, Kapetanovic, Meliha C, van Laar, Jacob M et al. · 2019 · RMD Open
24. Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment
    Younghoon Jeon · 2015 · The Korean journal of pain
25. Role of T lymphocyte replicative senescence in vaccine efficacy
    Effros, Rita B. · 2007 · Vaccine
26. Augmenting Immune Responses to Varicella Zoster Virus in Older Adults: A Randomized, Controlled Trial of Tai Chi
    Michael R. Irwin, Richard E. Olmstead, Michael N. Oxman · 2007 · Journal of the American Geriatrics Society
27. Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years
    Hung Fu Tseng, Rafael Harpaz, Yi Luo, Craig M. Hales, Lina S. Sy, Sara Yee Tartof, Stephanie R. Bialek, Rulin C. Hechter, Steven J. Jacobsen · 2016 · The Journal of Infectious Diseases
28. Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
    Chlibek, R., Bayas, J. M., Collins, H., de la Pinta, M. L. R., Ledent, E., Mols, J. F., Heineman, T. C. · 2013 · Journal of Infectious Diseases
29. A Reappraisal of Humoral Immunity Based on Mechanisms of Antibody‐Mediated Protection Against Intracellular Pathogens
    Arturo Casadevall, Liise‐anne Pirofski · 2006 · Advances in immunology
30. Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
    Najoua Dendouga, Michel Fochesato, Laurence Lockman, Sally P. Mossman, Sandra L. Giannini · 2012 · Vaccine
31. The ageing B cell population: Composition and function
    Alexander Ademokun, Yu-Chang Bryan Wu, Deborah K. Dunn‐Walters · 2009 · Biogerontology
32. Vaccines: Vaccination in Patients with Chronic Rheumatic or Autoimmune Diseases
    T. Glück, Ulf Müller‐Ladner · 2008 · Clinical Infectious Diseases
33. A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
    Leroux-Roels, Isabel, Leroux-Roels, Geert, Clement, Frédéric, Vandepapelière, Pierre, Vassilev, Ventzislav, Ledent, Edouard, Heineman, Thomas C. · 2012 · The Journal of Infectious Diseases
34. Cost-Effectiveness of a Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
    Michael B. Rothberg, A. Virapongse, Kenneth J. Smith · 2007 · Clinical Infectious Diseases
35. The burden of Herpes Zoster: A prospective population based study
    F SCOTT, Rachel Johnson, M. Leedham-Green, E DAVIES, W EDMUNDS, Judith Breuer · 2005 · Vaccine
36. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    James M. Pellissier, Marc Brisson, Myron J. Levin · 2007 · Vaccine
37. JAK inhibitors and infections risk: focus on herpes zoster
    Flavia Sunzini, Iain McInnes, Stefan Siebert · 2020 · Therapeutic Advances in Musculoskeletal Disease
38. Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses
    Stephen N. Crooke, Inna G. Ovsyannikova, Gregory A. Poland, Richard B. Kennedy · 2019 · Experimental Gerontology
39. Research design considerations for chronic pain prevention clinical trials
    Jennifer S. Gewandter, Robert H. Dworkin, Dennis C. Turk, John T. Farrar, Roger Benton Fillingim, Ian Gilron, John D. Markman, Anne Louise Oaklander, Michael J. Polydefkis, Srinivasa Naga Raja et al. · 2015 · Pain
40. Herpes zoster as a risk factor for stroke and TIA
    Judith Breuer, Maud Pacou, Aline Gauthier, Martin M. Brown · 2014 · Neurology
41. Annual incidence rates of herpes zoster among an immunocompetent population in the United States
    Barbara H. Johnson, Liisa A. Palmer, Justin D. Gatwood, Gregory M. Lenhart, Kosuke Kawai, Camilo J. Acosta · 2015 · BMC Infectious Diseases
42. Review: The neurobiology of varicella zoster virus infection
    Don Gilden, Ravi Mahalingam, Maria A. Nagel, Subbiah Pugazhenthi, Randall J. Cohrs · 2011 · Neuropathology and Applied Neurobiology
43. Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections
    Andreas Sauerbrei · 2016 · European Journal of Clinical Microbiology & Infectious Diseases
44. Opportunistic Infections Due to Inflammatory Bowel Disease Therapy
    Maneesh Dave, Treta Purohit, Raymund Rabe Razonable, Edward V. Loftus · 2013 · Inflammatory Bowel Diseases
45. Vaccine development: From concept to early clinical testing
    Anthony Lawrence Cunningham, Nathalie Garçon, Oberdan Léo, Leonard R. Friedland, Richard A. Strugnell, Béatrice Laupèze, Mark T. Doherty, Peter L. Stern · 2016 · Vaccine
46. The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination
    Hester E. de Melker, Guy A. M. Berbers, Susan Hahné, Hans C Rümke, Susan van den Hof, G. Ardine de Wit, Hein J. Boot · 2006 · Vaccine
47. Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
    Roman Chlíbek, Jan Smetana, Karlis Pauksens, Lars Rombo, Janet A Hoek, Jan Hendrik Richardus, Georg Plassmann, Tino F. Schwarz, Edouard Ledent, Thomas Charles Heineman · 2014 · Vaccine
48. Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
    Park, Jin Kyun, Lee, Min Ah, Lee, Eun Young, Song, Yeong Wook, Choi, Yunhee, Winthrop, Kevin L, Lee, Eun Bong · 2017 · Annals of the Rheumatic Diseases
49. The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine
    Kenneth E. Schmader, John W. Gnann, C. Peter N. Watson · 2008 · The Journal of Infectious Diseases
50. Varicella-Zoster Virus Infections
    Anne A. Gershon · 2007 · Pediatrics in Review
51. Advances and challenges in neuropathic pain: a narrative review and future directions
    Nadine Attal, Didier Bouhassira, Lesley Colvin · 2023 · British Journal of Anaesthesia
52. Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
    John C Hornberger, Katherine Robertus · 2006 · Annals of Internal Medicine
53. Zoster Vaccine: Current Status and Future Prospects
    Michael N. Oxman · 2010 · Clinical Infectious Diseases
54. History of Vaccine Development
    Stanley Alan Plotkin · 2011 · Springer eBooks
55. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008
    Judith Breuer, Charles F. Grose, P. Norberg, Graham A. Tipples, D. Scott Schmid · 2010 · Journal of General Virology
56. Herpes zoster and postherpetic neuralgia
    Robert W Johnson · 2010 · Expert Review of Vaccines
57. Difficulties in recruiting older people in clinical trials: An examination of barriers and solutions
    Iman Ridda, Chandini Raina MacIntyre, Richard I. Lindley, Timothy C. Tan · 2009 · Vaccine
58. Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
    Steven A. Pergam, Ajit P. Limaye, the AST Infectious Diseases Community of Practice · 2019 · Clinical Transplantation
59. Predictors of Postherpetic Neuralgia Among Patients With Herpes Zoster: A Prospective Study
    Mélanie Drolet, Marc Brisson, Kenneth E. Schmader, Myron J. Levin, Robert W. Johnson, Michael N. Oxman, David M. Patrick, Stéphanie Camden, James A. Mansi · 2010 · Journal of Pain
60. Viral Infection after Renal Transplantation
    Blair C. Weikert, Emily A. Blumberg · 2008 · Clinical Journal of the American Society of Nephrology
61. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults
    Catherine Amlie‐Lefond, Don Gilden · 2016 · Journal of Stroke and Cerebrovascular Diseases
62. Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine
    Thomas Charles Heineman, Anthony Lawrence Cunningham, Myron J. Levin · 2019 · Current Opinion in Immunology
63. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom
    Albert Jan van Hoek, Alessia Melegaro, Nigel J Gay, Joke Bilcke, W. John Edmunds · 2011 · Vaccine
64. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
    Stephanie F. James, Elias B. Chahine, Allana J. Sucher, Cassandra Hanna · 2018 · Annals of Pharmacotherapy
65. Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005
    Julia M.L. Brotherton, Han Wang, Andrea L. Schaffer, Helen Quinn, Robert Quinn, Brynley P. Hull, Glenda L. Lawrence, James Wood, Nicolas Wood, Alexander E. Rosewell et al. · 2007 · Communicable Diseases Intelligence
66. Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies
    Kim Alexander Papp, Boulos Paul Haraoui, Deepali Kumar, John Kenneth Marshall, Robert Bissonnette, Alain Bitton, Brian L. Bressler, Melinda Gooderham, VINCENT C. HO, Shahin Jamal et al. · 2018 · Journal of Cutaneous Medicine and Surgery
67. Severe complications of chickenpox in hospitalised children in the UK and Ireland
    J. Claire Cameron, G Allan, F Johnston, Adam H.R. Finn, Paul Trafford Heath, Robert Booy · 2007 · Archives of Disease in Childhood
68. Overview: Cytomegalovirus and the Herpesviruses in Transplantation
    Jay Alan Fishman · 2013 · American Journal of Transplantation
69. Postherpetic neuralgia: epidemiology, pathophysiology and management
    Robert W Johnson, Gunnar L. Wasner, Patricia Saddier, Ralf Baron · 2007 · Expert Review of Neurotherapeutics
70. Clinical Practice Guideline for the Evaluation of Fever and Infection in Older Adult Residents of Long‐Term Care Facilities: 2008 Update by the Infectious Diseases Society of America
    Kevin P. High, Suzanne Bradley, Stefan Gravenstein, David R. Mehr, Vincent Quagliarello, Chesley L. Richards, Thomas T. Yoshikawa · 2009 · Journal of the American Geriatrics Society
71. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review
    Benson Ogunjimi, Pierre Van Damme, Philippe Beutels · 2013 · PLoS ONE
72. The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
    Kevin L. Winthrop, Ann Wouters, Ernest Choy, Koshika Soma, Jennifer A. Hodge, Chudy I. Nduaka, Pinaki Biswas, Elie Needle, Sherry Passador, Christopher F. Mojcik et al. · 2017 · Arthritis & Rheumatology
73. Influence of Age and Nature of Primary Infection on Varicella‐Zoster Virus–Specific Cell‐Mediated Immune Responses
    Adriana Weinberg, Ann Lazar, Gary O. Zerbe, Anthony R Hayward, Ivan S. F. Chan, Rupert Vessey, Jeffrey L. Silber, Rob Roy MacGregor, Kenny Chan, Anne A. Gershon et al. · 2010 · The Journal of Infectious Diseases
74. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
    Roman Chlíbek, Karlis Pauksens, Lars Rombo, Gini G.C. van Rijckevorsel, Jan Hendrik Richardus, Georg Plassmann, Tino F. Schwarz, Grégory Catteau, Himal Lal, Thomas Charles Heineman · 2015 · Vaccine
75. Herpes zoster – typical and atypical presentations
    Roy Rafael Dayan, Roni Peleg · 2017 · Postgraduate Medicine
76. Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review
    Catherina X. Pan, Michelle S. Lee, Vinod E. Nambudiri · 2022 · Therapeutic Advances in Vaccines and Immunotherapy
77. Epidemiological Features and Costs of Herpes Zoster in Taiwan: a National Study 2000 to 2006
    JS Jih, Yi–Ju Chen, MW Lin, Yu‐Chun Chen, TJ Chen, YL Huang, Chih‐Cheng Chen, D.-D. Lee, Yu‐Tzu Chang, WJ Wang et al. · 2009 · Acta Dermato Venereologica
78. Herpes zoster in Germany: Quantifying the burden of disease
    B. Ultsch, Anette Siedler, Thorsten Rieck, Thomas Reinhold, Gérard Krause, Ole Wichmann · 2011 · BMC Infectious Diseases
79. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England
    Albert Jan van Hoek, Alessia Melegaro, Emelio Zagheni, W. John Edmunds, Nigel J Gay · 2011 · Vaccine
80. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older
    Alicia Stein, Helena C. Britt, Christopher M Harrison, E. Lynne Conway, Anthony Lawrence Cunningham, Chandini Raina MacIntyre · 2008 · Vaccine
81. Herpes Simplex and Varicella Zoster Viruses: Forgotten but Not Gone
    G G Miller, J. Stephen Dummer · 2007 · American Journal of Transplantation
82. Barriers to the Use of Herpes Zoster Vaccine
    Laura P. Hurley, Megan C. Lindley, Rafael Harpaz, Shannon Stokley, Matthew F. Daley, Lori A. Crane, Fran Dong, Brenda L. Beaty, Litjen Tan, Christine Babbel et al. · 2010 · Annals of Internal Medicine
83. Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis
    Fawziah Marra, Elaine Ah‐Gi Lo, Viktor Kalashnikov, Kathryn Richardson · 2016 · Open Forum Infectious Diseases
84. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
    Angelika Wagner, Birgit Weinberger · 2020 · Frontiers in Immunology
85. Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.
    Michael S. Simberkoff, Robert D. Arbeit, Gary R. Johnson, Michael N. Oxman, Kathy D Boardman, Heather Williams, Myron J. Levin, Kenneth E. Schmader, Lawrence D. Gelb, Susan K. Keay et al. · 2010 · PubMed
86. Herpes Zoster and Postherpetic Neuralgia
    Robert W Johnson, Gunnar L. Wasner, Patricia Saddier, Ralf Baron · 2008 · Drugs & Aging
87. Immunological control of herpes simplex virus infections
    Kevin P. Egan, Sharon Wu, Brian L. Wigdahl, Stephen R. Jennings · 2013 · Journal of NeuroVirology
88. Epidemiology of Herpes Zoster Ophthalmicus
    Kimberly D. Tran, Michelle M. Falcone, Daniel S. Choi, Raquel Goldhardt, Carol L. Karp, Janet L. Davis, Anat Galor · 2016 · Ophthalmology
89. A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61
    Daniel Pearce Depledge, Werner J. D. Ouwendijk, Tomohiko Sadaoka, Shirley E. Braspenning, Yasuko Mori, Randall J. Cohrs, Georges M. G. M. Verjans, Judith Breuer · 2018 · Nature Communications
90. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Michael N. Oxman · 2009 · PubMed
91. Management of Herpes Zoster and Post-Herpetic Neuralgia
    Emily Yiping Gan, Elizabeth A.L. Tian, Hong Liang Tey · 2013 · American Journal of Clinical Dermatology
92. Herpes Zoster and Postherpetic Neuralgia Surveillance Using Structured Electronic Data
    Michael Klompas, Martin Kulldorff, Yury Vilk, Stephanie R. Bialek, Rafael Harpaz · 2011 · Mayo Clinic Proceedings
93. Herpes Zoster
    Kenneth E. Schmader · 2018 · Annals of Internal Medicine
94. The Impact of the Varicella Vaccination Program on Herpes Zoster Epidemiology in the United States: A Review
    Meredith A. Reynolds, Sandra S. Chaves, Rafael Harpaz, Adriana S. Lopez, Jane F. Seward · 2008 · The Journal of Infectious Diseases
95. A population based study of the epidemiology of Herpes Zoster and its complications
    Dahlia Weitzman, Oren Shavit, Michal Stein, Raanan Cohen, Gabriel Chodick, Varda Shalev · 2013 · Journal of Infection
96. Herpes zoster
    David W. Wareham, Judith Breuer · 2007 · BMJ
97. Immune senescence and vaccines to prevent herpes zoster in older persons
    Myron J. Levin · 2012 · Current Opinion in Immunology
98. Central nervous system infections produced by varicella zoster virus
    Maria A. Nagel, Christy S. Niemeyer, Andrew N. Bubak · 2020 · Current Opinion in Infectious Diseases
99. Increased incidence of herpes zoster among patients with systemic lupus erythematosus
    Eliza F. Chakravarty, Kaleb D. Michaud, Robert S. Katz, Fred Wolfe · 2012 · Lupus
100. Persistent Sleep Disturbance: A Risk Factor for Recurrent Depression in Community-Dwelling Older Adults
     Lee, Eun, Cho, Hyong Jin, Olmstead, Richard, Levin, Myron J., Oxman, Michael N., Irwin, Michael R. · 2013 · Sleep